+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04748770

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-06-15

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Obesity affects about 35% of the global population and is linked to higher risks of cardiovascular problems, diabetes, and chronic kidney disease. This study focuses on obese patients who are starting dialysis, as they make up about 25% of the dialysis population but face restricted access to kidney transplants. The reasons behind this limited access in a highly affected region are not fully understood. The research observes two groups of patients based on their body mass index BMI those with BMI of 30 kgm2 or higher and those with BMI between 25 and 30 kgm2, starting one month after dialysis begins. The study does not involve any treatments or interventions but monitors these patients over time to understand differences in their transplant status. Participants will be followed for two years after starting dialysis, with data collected on their pre-transplant status and other health factors. Researchers will measure changes in transplant eligibility and access between the groups. The study collects and analyzes patient data without altering their usual care, aiming to provide insights into transplant access challenges for obese dialysis patients.

CONDITIONS

Brief Title

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Research Team

P

Pauline Caillard, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here